DOI: 10.1055/s-00000007

Aktuelle Urologie

LinksClose Window

References

Rini BI. et al.
Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma.

N Engl J Med 2019;
380: 1116-1127

Download Bibliographical Data

Access:
Access:

We do not assume any responsibility for the contents of the web pages of other providers.